Correspondence 0001104659-23-056580 from BELITE BIO, INC (BLTE) (CIK 0001889109) (BLTE)
BELITE BIO, INC (BLTE) (CIK 0001889109)
Date: May 5, 2023 · CIK: 0001889109 · Accession: 0001104659-23-056580
AI Filing Summary & Sentiment
File numbers found in text: 333-271549
Letter
May 5, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C.
Attention: Jimmy McNamara
Re: BELITE BIO, INC.
Registration Statement on Form F-3
Filed May 1, 2023
File No. 333-271549
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 of the Rules and Regulations of the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Belite Bio, Inc (the “Company”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) be accelerated to, and that the Registration Statement become effective at, 4:00 PM (Eastern time) on May 9, 2023, or as soon thereafter as practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Robert Plesnarski (+1 (202) 383-5149) or Portia Ku (+1 (212) 326-2168) of O’Melveny & Myers LLP, counsel to the Company. Thank you for your assistance with this matter.
[Signature page follows]
Very truly yours,
BELITE BIO, INC
Show Raw Text
CORRESP
1
filename1.htm
May 5, 2023
VIA EDGAR
United States
Securities and Exchange Commission
Division of Corporation
Finance
Office of Life
Sciences
100 F Street,
N.E.
Washington, D.C.
20549
Attention: Jimmy
McNamara
Re: BELITE BIO, INC.
Registration Statement on Form F-3
Filed May 1, 2023
File No. 333-271549
Ladies and Gentlemen:
Pursuant to Rules 460 and 461
of the Rules and Regulations of the U.S. Securities and Exchange Commission (the “Commission”) under the Securities
Act of 1933, as amended, Belite Bio, Inc (the “Company”), hereby requests that the effectiveness of the above-referenced
Registration Statement on Form F-3 (the “Registration Statement”) be accelerated to, and that the Registration Statement
become effective at, 4:00 PM (Eastern time) on May 9, 2023, or as soon thereafter as practicable.
Once the Registration Statement
has been declared effective, please orally confirm that event with Robert Plesnarski (+1 (202) 383-5149) or Portia Ku (+1 (212) 326-2168)
of O’Melveny & Myers LLP, counsel to the Company. Thank you for your assistance with this matter.
[Signature page follows]
Very truly yours,
BELITE BIO, INC
By:
/s/ Yu-Hsin Lin
Name: Yu-Hsin Lin
Title: Chief Executive Officer and
Chairman